<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 4 Issue 3 </issue_number>
<issue_period>2013 (July - September)</issue_period>
<title>ANTIAMNESIC EFFECT OF BERBERINE IN COLCHICINES INDUCED EXPERIMENTAL ALZHEIMER'S DISEASE MODEL </title>
<abstract>Central administration of colchicine is well known to cause cognitive impairment and oxidative damage, which simulates sporadic dementia of the Alzheimer type in humans. Berberine, a natural product alkaloid, has been shown to display a wide array of pharmacological effects. The present study has been designed to investigate the effects of berberine against the colchicine-induced cognitive impairment in mice. Memory performance task was accessed using Morris water maze. Colchicine (15µg/5µL) was administered ICV, resulted in poor memory retention in the Morris water maze task. Mice received chronic treatment of four doses (5, 10, 20, 40mg/kg per day, PO) of berberine for a period of 21 days beginning 4 days prior to colchicine administration. Berberine treatment significantly ameliorated learning deficits, long-term spatial memory retention. Our results suggest that berberine provides antiamnesic effects in colchicines induced memory impairment model and promising agent for the treatment of AD.</abstract>
<authors>SHUBHADA V. MANGRULKAR, ROHINI D. SELOTE, DINESH R. CHAPLE AND A.J CHOURASIA .</authors>
<keywords>Alzheimer's disease (AD), Morris Water Maze; Berberine, Colchicine, Memory</keywords>
<pages>618-628</pages>
</article>
</Journal>
